GLP-1 Receptor Agonists Linked to Lower Glaucoma Risk Compared to Metformin in Type 2 Diabetes Patients: Study Medha Baranwal25 Sept 2024 8:30 PM ISTUSA: A recent comparative study has uncovered promising evidence that GLP-1 receptor agonists may offer significant ocular benefits over metformin for...
GLP-1 Receptor Agonists Linked to Lower Risk of Cirrhosis Progression in Early-Stage Metabolic Liver Disease, Study Finds Medha Baranwal23 Sept 2024 8:00 AM ISTUSA: Recent findings from a cohort study have highlighted the potential benefits of GLP-1 receptor agonists (GLP-1 RAs) in managing patients with...
Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes, suggests study Dr. Kamal Kant Kohli12 Jun 2024 9:45 AM ISTGLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications...
Liraglutide-Associated Depression in Type 2 Diabetes Patient: Case Report Raises Concerns Medha Baranwal7 Jun 2024 9:00 AM ISTChina: A recent case report has drawn attention to a potential association between liraglutide, a commonly prescribed medication for type 2 diabetes,...
No separate preoperative Fasting Guidelines required for Diabetics to prevent perioperative pulmonary aspiration: Study Dr Riya Dave9 May 2024 9:30 PM ISTResearchers have found that people with diabetes do not have higher gastric volumes than those without diabetes after following standard preoperative...
GLP-1 analogues do not increase thyroid cancer risk, suggests BMJ study Dr. Kamal Kant Kohli10 April 2024 8:30 PM ISTDrugs known as GLP-1 analogues have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase...
Advancing therapy with iGlarLixi safe and effective for diabetes treatment irrespective of SGLT2 inhibitors use: Study Medha Baranwal3 April 2024 2:15 AM ISTA patient-level pooled analysis of three randomized clinical trials (RCTs) revealed improvement in glycemic status without increased risk of...
ADA releases Standards of Care 2024 with new screening and obesity management recommendations for diabetics Medha Baranwal13 Dec 2023 11:45 AM ISTUSA: The American Diabetes Association (ADA) has released new screening and obesity management recommendations for diabetes patients. The updated...
Prenatal use of GLP-1 RAs and other second-line antidiabetics do not increase congenital malformations risk in infants Dr. Kamal Kant Kohli13 Dec 2023 11:15 AM ISTUSA: A recent study published in JAMA Internal Medicine has provided reassurance of the safety of GLP-1 receptor agonists and other noninsulin...
GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
GLP-1 receptor agonists and SGLT-2 inhibitors reduce COPD exacerbations among diabetes patients Aditi7 Dec 2022 10:45 AM ISTCanada: A recent study published in the BMJ has highlighted that glucagon-like peptide 1 (GLP-1) receptor agonists, and sodium-glucose...
What ADA's recent consensus on hyperglycemia management has to say about GLP-1 receptor agonists Medha Baranwal25 Oct 2022 10:00 AM ISTUSA: A glucagon-like peptide-1 receptor agonist (GLP-1 RA) should be used to reduce MACE in people with established cardiovascular disease (CVD), a...
